Abstract
In this issue of Blood , [Rijal et al][1] have identified the inositol polyphosphate 4-phosphatase II (INPP4B) as a poor prognostic marker in acute myeloid leukemia (AML), driving chemoresistance through a novel gain-of-function mechanism independent of its phosphatase functions.[1][2] Although
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
